Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03702725 · COMPLETED
Trial details
- NCT number
- NCT03702725
- Sponsor
- Alliance Foundation Trials, LLC.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-29
- Primary completion
- 2024-09-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.